HTLV testing in blood transfusion

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 165-169

  Courouce A M ^a   Pillonel, J ^b   Lemaire, J M ^c   Saura, C ^d  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Reseau Natl de S Publique   (France)

^c Etablissement de Transfus Sanguine   (France)

^d Directeur Medical et Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CONFERENCE PAPER; EUROPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; JAPAN; POLICY; PREVALENCE; PRIORITY JOURNAL; SAFETY; SCREENING; SEROCONVERSION; UNITED STATES; VIRUS DETECTION;

EID: 0031871419     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05416.x     Document Type: Conference Paper

References (25)

1. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad. Sci USA 1980;77:7415-9.
2. Kalyanaraman VS, Sarngadharan MG, Poiesz B, Ruscetti FW, Gallo RC. Immunological properties of a type-C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol 1981;38:906-15.
3. Meytes D, Schochat B, Lee H, Nadel G, Sidi Y, Cerney M, Swason P, Shaklai M, Kilim Y, Elgat M, Chin E, Danon Y, Rosenblatt JD : Serological and molecular survey for HTLV-1 infection in a high-risk Middle Eastern group. Lancet 1990;336:1533-1535.
4. Blattner WA, Takatsuki K, Gallo RC. Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. JAMA 1983;250:1074-80.
5. Gessain A, Barin E, Vernant JC, Gout O, Maurs L, Calender A, de Thé G. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;ii:407-10.
6. Murphy El, Engstrom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG and the REDS Investigators. HTLV-II associated myelophathy in 43-year-old woman. Lancet 1993;341:757-758.
7. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645.
8. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, Nemo G, and the REDS investigators. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology 1997;48:315-320.
9. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of Adult T Cell Leukemia Virus by blood transfusion : Seroconversion in recipients. Vox Sang. 1984;46:245-253.
10. Kleinman S, Swanson P, Allain JP, and Lee H. Transfusion transmission of human T-lymphotropic virus types I and II : serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion. 1993;31:14-18.
11. Herr V, Ambruso D, Fairfax M, Neumann A, Swanson P, and Lee H. Transfusion-associated transmission of human T-lymphotropic virus types I and II : experience of a regional blood center. Transfusion 1993;33:208-211
12. Hjelle B, Wilson C, Cyrus S, Bradshaw P, Lo J, Schammel C, Wiltbank T, and Alexander S. Human T-Cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood 1993;81:1641-44.
13. Lal RB, Brodine S, Kazure J, Katongs EM, Yanagihara R, and Roberts C. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21) spiked western immnoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. J Clin Microbiol 1992;30:296-299.
14. Couroucé AM. Universal screening for anti-HTLV should be introduced by blood banks in all industrialised countries. Med Virol 1993;3:67-74.
15. Manns A, Murphy EL, Wilks RJ, Haynes G, Figueroa JP, Hanchard B, Palker TJ, Blattner WA. Early antibody profile during HTLV-I seroconversion. Lancet 1991;337:181-182.
16. Defer C, Coste J, Descamps F, Voisin S, Lemaire JM, Maniez M, Couroucé AM, and the Retrovirus Study Group of the French Society of Blood Transfusion. Contribution of polymerase chain reaction and radioimmuno-precipitation assay in the confirmation of human T-Lymphotropic virus infection in French blood donors. Transfusion 1995;35:596-600.
17. Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Switzer WM, Kleinman S, Busch M, Schreiber GB, and the Retrovirus Epidemiology Donor Study Group. Male-to-female transmission of human T-Cell lymphotropic virus types I and II : association with viral load. J Acquir Immune Defic Syndr Human Retrovirol 1996;12:193-201.
18. Lee H.H, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WS, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M, Kleinman SH. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991;337:1435-39.
19. Couroucé A.M, Pillonel J, Lemaire J.M, Maniez M, and Brunet JB. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993;7:841-847.
20. Zaaijer HL, Cuypers HTM, Dudok de Wit C, Lelie PN. Results of 1-year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I : significance of western blot patterns for confirmation of HTLV infection. Transfusion 1994;34:877-880.
21. The HTLV European Research Network. Seroepidemiology of the Human T-Cell Leukaemia/Lymphoma Viruses in Europe. J Acquir Immune Defic Syndr Human Retrovirol 1996;13:68-77.
22. Taylor GP. The Epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Human Retrovirol 1996;13:S8-S14.
23. Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Co Chien H, and Nass CC for the NHLBI Retrovirus Epidemiology Donor Study. Risk Factor for Human T-Cell Lymphotropic Virus Types I and II (HTLV-I and -II) in blood Donors : The Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Human Retrovirol 1997;14:263-271.
24. Couroucé AM, Pillonel J, for the Retrovirus and Viral Hepatitis working Groups of the French Society of Blood Transfusion. Transfusion-Transmitted Viral Infections. N. Engl. J. Med. 1996;335:1609-1610.
25. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, for the Retrovirus Epidemiology Donor Study. The risk of Transfusion-Transmitted viral infections. N. Engl. J. Med. 1996;334:1685-90.